Roadzen (NASDAQ: RDZN) awards director 152,732 stock options at $2
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Roadzen Inc. director Adhikari Saurav received a new stock option grant. On 09/15/2025, he was awarded stock options to purchase 152,732 ordinary shares at an exercise price of $2 per share. The options were acquired at a price of $0 and are exercisable starting 09/15/2025, with an expiration date of 09/15/2032. Following this grant, he beneficially owns 152,732 derivative securities directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Adhikari Saurav
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 152,732 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 152,732 shares (Direct)
Footnotes (1)
FAQ
What insider transaction did Roadzen Inc. (RDZN) report for Adhikari Saurav?
Roadzen Inc. reported that director Adhikari Saurav received a grant of stock options on 09/15/2025, covering 152,732 ordinary shares.
How many Roadzen (RDZN) stock options were granted to the director?
Director Adhikari Saurav was granted 152,732 stock options, each representing the right to buy one ordinary share of Roadzen Inc.
What is the exercise price and term of the Roadzen (RDZN) options granted?
The stock options have an exercise price of $2 per share, became exercisable on 09/15/2025, and expire on 09/15/2032.
Did Adhikari Saurav pay anything to receive these Roadzen (RDZN) options?
No. The filing shows the options were acquired at a price of $0, which is typical for equity awards granted as compensation.
How many Roadzen (RDZN) derivative securities does the director own after this transaction?
After the grant, 152,732 derivative securities (stock options) are reported as beneficially owned directly by Adhikari Saurav.
Is this Roadzen (RDZN) insider transaction a purchase or a sale?
The transaction is coded "A" for acquisition, indicating that it is an award of stock options, not a sale of existing shares.